- Trnh sn phm tip xc trc tip vi mt, ra li vi nc sch nu sn phm dnh vo mt
Adults with a body mass index of at least 27 who initiated injectable semaglutide or tirzepatide between July 1, 2022 and December 31, 2024, were eligible
Below 95%, the impurity load becomes significant enough to potentially confound research results
One reconstitution, one inventory line, one CoA
She also serves as a physician consultant on substance use disorders to the Behavioral Health Administration in the Maryland Department of Health and is the Managing Partner of Uzima Consulting Group, LLC, which provides addiction medicine-related consultation, education and training, and expert witness testimony